EZH2 and acute myeloid leukemia: Although our results revealed that the enzyme activity of KDM5C was not required for this regulation, epigenetic modifiers, such as the DNA methyltransferase DNMT3A [34] and histone methyltransferase EZH2 [35, 36], could regulate the disease stages of AML.